These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5515417)

  • 21. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice.
    Pfeifer AK; Galambos E
    Psychopharmacologia; 1967; 11(2):130-5. PubMed ID: 5588185
    [No Abstract]   [Full Text] [Related]  

  • 23. Selective protection of serotonin stores against the action of reserpine by -methyl-5-hydroxytryptpohan pretreatment.
    Lahti RA; Platz PA
    Biochem Pharmacol; 1969 Oct; 18(10):2363-9. PubMed ID: 4397869
    [No Abstract]   [Full Text] [Related]  

  • 24. The relationship between brain norepinephrine and aggressive behavior.
    Reis DJ
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():266-97. PubMed ID: 4341950
    [No Abstract]   [Full Text] [Related]  

  • 25. Biosynthesis of cerebral phenolic amines. II. In vivo regional formation of p-tyramine and octopamine from tyrosine and dopamine.
    Boulton AA; Wu PH
    Can J Biochem; 1973 Apr; 51(4):428-35. PubMed ID: 4572198
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical pharmacology of benzo(b)thiophene analogs of harmaline and harmine.
    Bosin TR; Campaigne E; Maickel RP
    Life Sci I; 1972 Jul; 11(14):685-91. PubMed ID: 4656100
    [No Abstract]   [Full Text] [Related]  

  • 27. Modification by desipramine (DMI) of the availability of norepinephrine released by reserpine in the hypothalamus of the rat in vivo.
    Sulser F; Owens ML; Strada SJ; Dingell JV
    J Pharmacol Exp Ther; 1969 Aug; 168(2):272-82. PubMed ID: 5803311
    [No Abstract]   [Full Text] [Related]  

  • 28. CENTRAL STIMULANT ACTIONS OF ALPHA-ALKYL SUBSTITUTED TRYPTAMINES IN MICE.
    LESSIN AW; LONG RF; PARKES MW
    Br J Pharmacol Chemother; 1965 Feb; 24(1):49-67. PubMed ID: 14301999
    [No Abstract]   [Full Text] [Related]  

  • 29. Biochemical evidence of adrenergic interaction with cholinergic function in the central nervous system of the rat. 1. Effect of norepinephrine.
    Ho AK; Singer G; Gershon S
    Psychopharmacologia; 1971; 21(3):238-46. PubMed ID: 4328762
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of binding of aldehydes of biogenic amines in tissues.
    Ungar F; Tabakoff B; Alivisatos SG
    Biochem Pharmacol; 1973 Aug; 22(15):1905-13. PubMed ID: 4722459
    [No Abstract]   [Full Text] [Related]  

  • 31. Changes in in vivo binding of 3H-Ro 15-1788 in mouse brain by reserpine.
    Hashimoto K; Inoue O; Goromaru T; Yamasaki T
    Int J Rad Appl Instrum B; 1988; 15(6):637-44. PubMed ID: 3150844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain biogenic amines and pituitary-adrenocortical function in the rat.
    Maickel RP; Martel RR
    Pharmacol Biochem Behav; 1983 Aug; 19(2):321-5. PubMed ID: 6634881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A reassessment of the mechanism of reserpine-produced sedation.
    Millard SA; Gál EM
    Biol Psychiatry; 1969 Jul; 1(3):219-25. PubMed ID: 5352653
    [No Abstract]   [Full Text] [Related]  

  • 34. Uptake and metabolism of [14C] serotonin in rat brain.
    Palaić D; Page IH; Khairallah PA
    J Neurochem; 1967 Jan; 14(1):63-9. PubMed ID: 6018081
    [No Abstract]   [Full Text] [Related]  

  • 35. An enzyme assay for norepinephrine in brain tissue.
    Saelens JK; Schoen MS; Kovacsics GB
    Biochem Pharmacol; 1967 Jun; 16(6):1043-9. PubMed ID: 6040387
    [No Abstract]   [Full Text] [Related]  

  • 36. Intrahypothalamic and intrastriatal dopamine and norepinephrine injections in relation to motor hyperactivity in rats.
    Benkert O; Köhler B
    Psychopharmacologia; 1972; 24(2):318-25. PubMed ID: 4260590
    [No Abstract]   [Full Text] [Related]  

  • 37. Subcellular distribution of 5-hydroxytryptamine in rat brain during development: effect of drugs and fasting.
    Tissari AH; Raunu EM
    J Neurochem; 1975 Jun; 24(6):1143-50. PubMed ID: 1079237
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on the metabolism of 5-hydroxytryptamine (serotonin). V. Reserpine-induced sedation without depletion of cerebral 5-hydroxytryptamine.
    Gál EM; Millard SA
    Life Sci; 1967 Dec; 6(23):2505-13. PubMed ID: 4865930
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.
    Björklund A; Baumgarten HG; Nobin A
    Adv Biochem Psychopharmacol; 1974; 10():13-33. PubMed ID: 4846535
    [No Abstract]   [Full Text] [Related]  

  • 40. Ethanol-induced spontaneous norepinephrine release from the rat vas deferens.
    Degani NC; Sellers EM; Kadzielawa K
    J Pharmacol Exp Ther; 1979 Jul; 210(1):22-6. PubMed ID: 448644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.